Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hay

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: medical cost algorithmsA R Hay, J W Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 9, 2009
Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitorsJ W Hay, Z-Y Zhou
American Journal of Public Health|August 1, 1994
The US economic and social costs of Alzheimer's disease revisitedR L Ernst, J W Hay
Medical Care Review|January 5, 1987
Medicare pricing mechanisms for physician services: an overview of alternative approachesF A Sloan, J W Hay
Pediatrics|September 1, 1987
Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infectionJ W Hay, R S Daum
Alzheimer Disease and Associated Disorders|January 1, 1997
Economic research on Alzheimer disease: a review of the literatureR L Ernst, J W Hay
Pharmacoeconomics|May 27, 1999
Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery diseaseJ W Hay, W M Yu, T Ashraf
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2013
Bypass therapy assay testing as a strategy to reduce costs for treatment of haemophilia patients with inhibitorsJ W Hay, S C Chaugule, G Young
Alzheimer Disease and Associated Disorders|January 23, 1998
The costs and social burdens of Alzheimer disease: what can and should be done?J W Hay, M Sano, P J Whitehouse
Social Science & Medicine (1982)|January 1, 1982
The demand for dental healthJ W Hay, H Bailit, D A Chiriboga
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: medical cost algorithmsA R Hay, J W Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 9, 2009
Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitorsJ W Hay, Z-Y Zhou
American Journal of Public Health|August 1, 1994
The US economic and social costs of Alzheimer's disease revisitedR L Ernst, J W Hay
Medical Care Review|January 5, 1987
Medicare pricing mechanisms for physician services: an overview of alternative approachesF A Sloan, J W Hay
Pediatrics|September 1, 1987
Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infectionJ W Hay, R S Daum
Alzheimer Disease and Associated Disorders|January 1, 1997
Economic research on Alzheimer disease: a review of the literatureR L Ernst, J W Hay
Pharmacoeconomics|May 27, 1999
Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery diseaseJ W Hay, W M Yu, T Ashraf
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2013
Bypass therapy assay testing as a strategy to reduce costs for treatment of haemophilia patients with inhibitorsJ W Hay, S C Chaugule, G Young
Alzheimer Disease and Associated Disorders|January 23, 1998
The costs and social burdens of Alzheimer disease: what can and should be done?J W Hay, M Sano, P J Whitehouse
Social Science & Medicine (1982)|January 1, 1982
The demand for dental healthJ W Hay, H Bailit, D A Chiriboga
Pageof 5